Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-linked inhibitor of apoptosis pseudogene 2 (XIAPP2) is a human non-coding gene classified as a pseudogene. It is located on chromosome 11 and annotated by the HGNC (HGNC:52376)[6]. Pseudogenes resemble true genes in sequence but contain mutations, deletions, or other changes that render them non-functional[2][4]. XIAPP2 shares sequence similarity with the protein-coding X-linked inhibitor of apoptosis (XIAP), but it does not encode a functional protein, participate in biochemical processes, or serve as a therapeutic target. Pseudogenes generally do not have direct roles in disease, molecular signaling, or drug development[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-linked inhibitor of apoptosis pseudogene 2 (XIAPP2).